Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 10, 2021
Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type
Marnix Mylemans, Louis Nevejan, Stefanie Van Den Bremt, et al.
The Journal of Rheumatology
|
October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activity
Bert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
Arthritis Research & Therapy
|
July 25, 2006
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays
Bert Vander Cruyssen, Tineke Cantaert, Leonor Nogueira, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2008
A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis
Pieter Dewint, Valerie Gossye, Karolien De Bosscher, et al.
Annals of the Rheumatic Diseases
|
March 16, 2011
Predicting the outcome of ankylosing spondylitis therapy
Nathan Vastesaeger, Désirée van der Heijde, Robert D Inman, et al.
Annals of the Rheumatic Diseases
|
October 5, 2018
Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial
Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2007
A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner
Ken Coppieters, Katrien Van Beneden, Peggy Jacques, et al.
Arthritis Research & Therapy
|
September 19, 2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 18, 2025
Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome
Lieve Van Hoovels, Silvia Piantoni, Els Bailleul, et al.
Arthritis Research & Therapy
|
October 7, 2005
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 10, 2021
Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type
Marnix Mylemans, Louis Nevejan, Stefanie Van Den Bremt, et al.
The Journal of Rheumatology
|
October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activity
Bert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
Arthritis Research & Therapy
|
July 25, 2006
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays
Bert Vander Cruyssen, Tineke Cantaert, Leonor Nogueira, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2008
A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis
Pieter Dewint, Valerie Gossye, Karolien De Bosscher, et al.
Annals of the Rheumatic Diseases
|
March 16, 2011
Predicting the outcome of ankylosing spondylitis therapy
Nathan Vastesaeger, Désirée van der Heijde, Robert D Inman, et al.
Annals of the Rheumatic Diseases
|
October 5, 2018
Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial
Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2007
A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner
Ken Coppieters, Katrien Van Beneden, Peggy Jacques, et al.
Arthritis Research & Therapy
|
September 19, 2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 18, 2025
Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome
Lieve Van Hoovels, Silvia Piantoni, Els Bailleul, et al.
Arthritis Research & Therapy
|
October 7, 2005
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, et al.
Page
of 4